Siolta Therapeutics raises $30m in series B investment round
Californian biotech Siolta Therapeutics has raised $30m in a series B investment round: with the financing to fund the clinical development of novel microbiome-based medicines.
Archives for September 22, 2020
ALSA Ventures closes US$59m European biotech venture capital fund
ALSA Ventures today announced first closing of its European biotechnology investment fund with commitments of US$59M.
Higher income economies sign up to global Covid-19 vaccine initiative, but not US, China or Russia
A project run by Gavi, the vaccine alliance, and the World Health Organization (WHO) to guarantee fair access to COVID-19 vaccines worldwide, has secured the backing of 64 higher income countries, with more set to sign up in the coming days.
Samsung Biologics and AstraZeneca launch strategic manufacturing partnership
Samsung Biologics and AstraZeneca have announced a $330.8m long-term global supply agreement: helping AstraZeneca expand biologics manufacturing capabilities in Asia Pacific.
Industry should work together to raise public understanding of clinical trials, says Innovative Trials
AstraZeneca paused its COVID-19 vaccine trial earlier this month for a safety review – generating headlines across mainstream press worldwide. Such pauses are not uncommon in clinical trials – so what’s the best way to deal with them?